Celecoxib As an in Vivo Probe of Cyclooxygenase-2 Mechanisms Underlying Retrograde Amnesia in an Animal Model of ECT
Overview
Physiology
Authors
Affiliations
Background: Cyclooxygenase-2 (COX-2) mechanisms are involved in glutamate-mediated learning and memory as well as in glutamatergic excitotoxicity. Electroconvulsive therapy (ECT)-induced amnesia may arise from glutamatergic excitotoxicity; if so, COX-2 inhibition may attenuate retrograde amnesia with ECT.
Methods: Wistar rats which received celecoxib (15 mg/kg per day) or vehicle for 18 days were trained for 3 days on a passive avoidance task. On each of the next 3 days, rats which showed perfect learning (n=51) received true or sham suprathreshold electroconvulsive shocks (ECS; 60 mC) in a factorial design; daily dosing with drug or vehicle was continued. One day after the last ECS, recall of pre-ECS learning was tested.
Results: ECS-treated rats showed impaired recall in the vehicle but not celecoxib group. Celecoxib significantly protected against ECS-induced retrograde amnesia; this benefit was independent of the drug-induced attenuation of ECS seizure duration.
Conclusions: Celecoxib may protect against ECS-induced retrograde amnesia by attenuating ECS-induced, COX-2-mediated glutamatergic excitotoxicity.
Searching for the mechanism(s) of ECT's therapeutic effect.
McCall W, Andrade C, Sienaert P J ECT. 2014; 30(2):87-9.
PMID: 24755719 PMC: 4695970. DOI: 10.1097/YCT.0000000000000121.
Nordgren M, Karlsson T, Svensson M, Koczy J, Josephson A, Olson L PLoS One. 2013; 8(11):e78778.
PMID: 24244357 PMC: 3828303. DOI: 10.1371/journal.pone.0078778.
Andrade C, Shaikh S, Narayan L, Blasey C, Belanoff J J Neural Transm (Vienna). 2011; 119(3):337-44.
PMID: 21922193 DOI: 10.1007/s00702-011-0712-8.
Andrade C Indian J Psychiatry. 2009; 50(4):244-52.
PMID: 19823608 PMC: 2755145. DOI: 10.4103/0019-5545.44745.
Andrade C Indian J Psychiatry. 2009; 50(3):209-12.
PMID: 19742183 PMC: 2738364. DOI: 10.4103/0019-5545.43631.